prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Basal, Provider Group : Date of Service: Date Received: A copy of this renant will be faxed to: FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: A. - C.) LEFT BREAST, ADDITIONAL ANTERIOR MARGIN, AND LEFT AXILLARY SENTINEL. LYMPH NODE. SIMPLE MASTECTOMY (INCLUDING RE-EXCISION OF. ANTERIOR MARGIN) AND SENTINEL NODE BIOPSY: - Invasive ductal carcinoma, Nottingham grade 3. [D:302E69E0-39F0-4CDB-97F9-A6CDDB307233. - Size: 2.6 cm in greatest dimension. - Location: 11:00. - No in situ component identified. - Margins: - Invasive carcinoma is widely free of all margins (at least 1 cm away). - Additional anterior margin consists of benign skin and subcutaneous tissue. - No lymphovascular invasion identified. - Two sentinel lymph nodes, negative for carcinoma (0/2). - Uninvolved breast parenchyma with focal fibroadenomatoid changes. - Benign skin and nipple with small intraductal papilloma. COMMENT: Breast carcinoma biomarker studies will be repeated on a representative. section of tumor (block A7) due to the focal weak to strong reactivity for ER and PR in. <1% tumor cells seen previously on core biopsy. The results will follow in an. addendum. PATHOLOGIC TUMOR STAGING SYNOPSIS: Type and grade (invasive): Invasive ductal carcinoma, Nottingham grade 3. Type and grade (in situ): N/A. Primary tumor: pT2. Regional lymph nodes: pNo(i-)(sn). Distant metastasis: N/A. Stage: IIA. Lymphovascular invasion: Not identified. Margin status: R0, negative. Printed: This report continues. Page 1/6. FINAL SURGICAL PATHOLOGY REPORT. Invasive Breast Cancer Tumor Staging Information. AJCC Cancer Staging Handbook, 7th Ed., and CAP Protocol (revised June 2012). Previous pathology specimens. Printed: This report continues. Page 2/6. SPECIMEN IDENTIFICATION. Simple mastectomy with re-excision of anterior. Procedure/specimen type: margin. Left breast. Laterality: Sentinel lymph node biopsy. Lymph node sampling: INVASIVE CARCINOMA TUMOR CHARACTERISTICS. Invasive ductal carcinoma. Histologic type: 11:00. Tumor site: 2.6 cm in greatest dimension. Tumor size: Unifocal. Tumor focality: 3 of 3 (Nottingham score 9 of 9). Histologic grade (Nottingham Score): 3 of 3. Tubule formation: 3 of 3. Nuclear pleomorphism: 3 of 3. Mitotic rate: Not identified. Lymphovascular invasion: Benign skin and nipple. Macroscopic and microscopic extent of tumor: Not identified. DUCTAL CARCINOMA IN SITU (DCIS): MARGINS. Widely free of all margins (at least 1 cm away). Invasive carcinoma: LYMPH NODES. 2 (sentinel nodes). Total lymph nodes examined. 0. Number of lymph nodes involved. N/A. Size of largest metastatic deposit: N/A. Extranodal extension: PATHOLOGIC STAGING: pT2. Primary Tumor (pT): Regional lymph nodes (pN): pNo(i-)(sn). N/A. Distant metastasis (pM): IIA. AJCC Stage: ANCILLARY STUDIES: Negative (less than 1% positive cells, weak. Estrogen receptor: intensity). Negative (less than 1% positive cells, strong. Progesterone receptor: intensity). Negative (score 0). HER2: High (70% positive cells). Ki-67: This report continues. Printed: - Page 3. Page 3/6. FINAL SURGICAL PATHOLOGY REPORT. Source of Specimen: A. Breast;left. B. Sentinel lymph node;left axillary. C. Breast;left additional anterior margin. Clinical History/Operative Dx: Malignant neoplasm of breast (female, left). Intraoperative Diagnosis: B. Left axillary sentinel lymph node. : No tumor cells identifier. Gross Description: A. Part A is designated as left breast - stitch = lateral. Initially received in the fresh state for possible. is an 862 gram left simple mastectomy, 26.8 cm medial-lateral, 20.8 cm. inferior-superior, and 4.0 cm posterior-anterior. The overlying ellipse of wrinkled, tan-brown skin is 26.3 x. 13.0 cm with a medial-inferior orientated, darkened brown, wrinkled areola, 4.8 cm in diameter with a. prominent 1.3 cm nipple. A double suture marks the lateral apex of the skin. A palpable mass is. appreciated in the upper inner quadrant (approximating 11:00). The surgical margins are now. differentially inked as follows: Superior superficial: Blue,. Inferior superficial: Orange,. Posterior: Black. Included within the container are two unoriented strips of wrinkled, tan-brown skin measuring 11.7 X 2.7 x. 0.7 cm and 10.3 X 2.4 X 1.3 cm each. Printed: This report continues. Page 4/6. FINAL SURGICAL PATHOLOGY REPORT. The breast is serially sectioned perpendicularly through the medial-lateral long axis to reveal a. well-demarcated, soft to rubbery, light gray, lobulated tumor mass measuring upwards of 2.6 x 2.5 x 2.3. cm (slabs 6-7, from medial). This tumor is placed grossly 1.0 cm from the superior superficial, 2.4 cm from. the deep and greater than 5.0 cm from the inferior superficial, most medial and most lateral surgical. margins. Along the medial periphery of the lesion is an embedded twisted radiologic marker. The remaining cut sections of the breast demonstrates admixed yellow-tan fibrofatty tissue without. additional discrete nodularity. No lymph node tissue is appreciated along the lateral periphery. Sectioning. through the remaining two strips of skin demonstrate unremarkable fibrofatty cut surfaces. Representative. sections are submitted. Cassette summary: A1) nipple,. A2) medial and lateral extension of skin,. A3) upper inner quadrant, slab 3,. A4) upper inner quadrant, slab 5, adjacent to tumor,. A5) upper inner quadrant, tumor and superior superficial surgical margin, slab 6,. A6-A7) upper inner quadrant, tumor and superior superficial surgical margin, contiguous sections, slab 6,. A8) upper inner quadrant, deep margin adjacent to tumor, slabs 6-7,. A9) upper inner quadrant-central superior, adjacent to tumor, slab 8,. A10-A11) lower inner quadrant, slabs 4 and 6, respectively,. A12-A13) lower outer quadrant, slabs 9 and 11, respectively,. A14-A15) upper outer quadrant, slabs 9 and 11, respectively,. A16-A17) representation of separate strips of skin and subcutaneous fat, two pieces each. B. Part B is left axillary sentinel lymph node. (frozen section). Initially received in the fresh state for. frozen section/touch prep analysis is a 6.0 X 3.0 x 1.0 cm pad of yellow-tan fatty soft tissue. Initial. sectioning reveals a single fatty pink and tan lymph node candidate, 2.0 cm in greatest dimension. Two. touch preparation slides are forwarded for microscopic evaluation. Further examination of the fat reveais. possible additional lymph node tissue up to 1.0 cm in greatest dimension. The largest lymph node is. entirely submitted for routine histology with a sentinel node protocol performed in B1 and B2, and the. additional/residual lymph node tissue candidacy is submitted in B3 and B4 for routine histology. C. Part C is additional anterior margin - left. Initially received in the fresh state is a 15 gram elliptical. excision of wrinkled tan-brown skin and subcutaneous fat, 11.1 x 2.6 x 1.5 cm. The margins are submitted. unoriented; the possible outer margin is now marked blue and the remaining surgical margins are marked. black. Sectioning demonstrates glistening, admixed yellow-tan fibrofatty tissue without discrete nodularity. or grossly unusual areas of change suggestive of residual or invasive tumor component. Representative. section are submitted for microscopic evaluation in C1-C5 (six pieces. Microscopic Description: A. - C.) Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. The sentinel nodes (part B) were evaluated by H&E levels and. cytokeratin immunostain. Controls are appropriate. Printed: This report continues. Page 5/6. FINAL SURGICAL PATHOLOGY REPORT. Printed: END OF REPORT (FINAL). Page 6/6.

expanded version (tokens=2385) : 
 According to the breast pathology report, the following information can be extracted:

- Histological classification: Invasive ductal carcinoma, Nottingham grade 3, with a subtype of Basal.
- Size: The tumor has a size of 2.6 cm in greatest dimension and is located at 11:00.
- In situ component: No in situ component was identified.
- Margins: The invasive carcinoma is widely free of all margins, and the additional anterior margin consists of benign skin and subcutaneous tissue.
- Tumor infiltrating lymphocytes: There is no mention of tumor infiltrating lymphocytes in the report.
- Histological grade: The Nottingham score for histologic grade is 3 of 3.
- Nuclear grade: Nuclear pleomorphism is 3 of 3, and the mitotic rate was not identified.
- Lymphovascular invasion: No lymphovascular invasion was identified.
- Calcification: No information regarding calcifications was included in the report.
- Receptor status: The report states that biomarker studies will be repeated on a representative section of tumor due to the focal weak to strong reactivity for estrogen and progesterone receptors in <1% of tumor cells seen previously on core biopsy. HER2 is positive with 70% positive cells, and Ki-67 is high.
- IHC and other ancillary testing results: The ancillary studies show less than 1% positive cells with weak intensity for estrogen receptor and less than 1

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2554) : 
 The patient has invasive ductal carcinoma, subtype Basal with a tumor size of 2.6 cm. No in situ component is identified and no lymphovascular invasion is noted. The histological grade is 3 of 3, and the estrogen and progesterone receptor status are being retested as there was a focal weak to strong reactivity earlier. HER2 is positive with 70% positive cells, and Ki-67 is high. Two sentinel lymph nodes are clear for carcinoma and breast parenchyma without tumor. The report suggests biomarker studies to follow in an addendum.

